These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 667817)

  • 1. In vivo perturbation of human marrow cell cycle progression by ifosfamide.
    Rentschler RE; Barlogie B; Johnston DA; Bodey GP
    Cancer Res; 1978 Aug; 38(8):2209-15. PubMed ID: 667817
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissues.
    Tew KD
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):24-7. PubMed ID: 7163812
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with ifosfamide in patients with malignant lymphoma.
    Rodriguez V; Cabanillas F; Bodey GP; Freireich EJ
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):87-92. PubMed ID: 7163815
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
    Semont H; Hecquet C; Adolphe M; Deysson G
    Exp Hematol; 1982 Oct; 10(9):782-8. PubMed ID: 7173344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse L1210V leukemia as a model to analyse efficiency of leukemic cell elimination by immunotoxin, antibody and complement, and cytostatic agents.
    Paprocka M; Wiedlocha A; Radzikowski C
    In Vivo; 1990; 4(3):209-13. PubMed ID: 2133264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell-kinetics in the acute leukaemias (author's transl)].
    Sánchez Fayos J; Outeiriño J; Calabuig MT
    Sangre (Barc); 1981; 26(5B):718-37. PubMed ID: 6948413
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
    Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma.
    Barlogie B; Hittelman W; Spitzer G; Trujilo JM; Hart JS; Smallwood L; Drewinko B
    Cancer Res; 1977 Dec; 37(12):4400-7. PubMed ID: 922731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of evaluating residual disease in bone marrow in malignant hemopathies. Prospectives].
    Hervé P; Favrot M
    Nouv Rev Fr Hematol (1978); 1987; 29(2):103-6. PubMed ID: 3302940
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible significance of nonproliferating leukemic cells.
    Mauer AM; Saunders EF; Lampkin C
    Natl Cancer Inst Monogr; 1969 May; 30():63-79. PubMed ID: 5351830
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia.
    Raza A; Maheshwari Y; Mandava N; Yasin Z; Perveen S; Mayers G; Browman G; Goldberg J; Gottlieb A; Grunwald H
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):217-25. PubMed ID: 3589695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of negative ions on spontaneous and cyclophosphamide-induced micronucleus frequency in mouse bone marrow polychromatophilic erythroblasts].
    Xie L; Yin AH; Song YP; Wang YC
    Yi Chuan Xue Bao; 1988; 15(5):368-73. PubMed ID: 3273680
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):285-91. PubMed ID: 3592932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM; Stong RC; Youle RJ; Vallera DA
    J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of an erythrocytic chalone on the postsynthetic period of the erythroblastic mitotic cell cycle in mouse bone marrow].
    Neustroev GV
    Arkh Anat Gistol Embriol; 1980 Jul; 79(7):69-73. PubMed ID: 6448032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
    Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
    Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.
    Blumenreich MS; Woodcock TM; Andreeff M; Hiddemann W; Chou TC; Vale K; O'Hehir M; Clarkson BD; Young CW
    Cancer Res; 1984 May; 44(5):2203-7. PubMed ID: 6713407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia.
    Danova M; Giordano M; Mazzini G; Riccardi A
    Leuk Res; 1990; 14(5):417-22. PubMed ID: 2140591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.